Theralase Inc.   Report issue

For profit Phase 1 Phase 2
Founded: Toronto ON Canada (1994)
Status: No NME R&D (1994)

Organization Overview

First Clinical Trial
2016
NCT03053635
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Theralase Inc.

Active Ingredients

Drugs in Phase 2 Trials (1)

tld-1433 (1 trial)

Drugs in Phase 1 Trials (1)

tld1433 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Urinary Bladder Neoplasms (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 2